Bailard, Inc. Ovid Therapeutics Inc. Transaction History

Bailard, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 02, 2023	BUY	$1.43 - $1.89 $1,144 - $1,512	800 Added 6.78%	12,600 $23,000
Q3 2022 Oct 18, 2022	BUY	$1.84 - $2.26 $21,712 - $26,667	11,800 New	11,800 $22,000
Q1 2022 Apr 25, 2022	SELL	$2.65 - $3.49 $127,062 - $167,338	-47,948 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$3.13 - $3.73 $150,077 - $178,846	47,948 New	47,948 $154,000

39M

37.4K

500

Ticker OVID
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,419,400
Market Cap $64.1M
Description
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...

Get notified when there are updates to the investment portfolio of Bailard, Inc., based on Form 13F filings with the SEC.

Stay updated on Bailard, Inc. with notifications on news.